Postinterventional homocysteine levels: Failure as a predictive biomarker of in-stent restenosis

International Journal of Cardiology

Volumn 108, Issue 1, 2006, Pages 20-25

  Breuckmann, F ^a   Naber, C ^a   Beckert, J ^a   Schmermund, A ^a   Haude, M ^a   Baumgart, D ^a   Erbel, R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Angiography; Homocysteine; In stent restenosis; Stent implantation

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CORONARY STENT; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; BLOOD; CORONARY ARTERY DISEASE; MIDDLE AGED; NONPARAMETRIC TEST; POSTOPERATIVE CARE; PREDICTION AND FORECASTING; PREGNANCY; RADIOGRAPHY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PREGNANCY; STATISTICS, NONPARAMETRIC; STENTS;

EID: 33644640707     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.03.059     Document Type: Article

References (41)

1. P. Teirstein, V. Massulo, S. Jani, J. Popma, R. Russo, and R. Schatz Three-year clinical and angiographic follow-up after intracoronary radiation Circulation 101 2000 360 365
2. A.E. Raizner, S.N. Oesterle, R. Walksman, P.W. Serruys, A. Colombo, and Y.L. Lim Inhibition of restenosis with β-emitting radiotherapy Report of the proliferation reduction with vascular energy trial (PREVENT) vol. 102 2000 951 958
3. R. Waksman, A. Raizner, A. Yeung, A. Lansky, and L. Vandertie Use of localised intracoronary β radiation in the treatment of in-stent restenosis: the INHIBIT randomised controlled trial Lancet 359 2002 551 557
4. J.E. Sousa, M.A. Costa, A.C. Abizaid, B.J. Rensing, L.F. Tanajura, and K. Kozuma Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 104 2001 2007 2011
5. F. Liistro, G. Stankovic, C. Di Mario, T. Takagi, A. Chieffo, and S. Moshiri First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis Circulation 105 2002 1883 1886
6. R. Erbel, M. Haude, H. Hoepp, D. Franzen, H. Rupprecht, and B. Heublein Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty N Engl J Med 339 1998 1672 1678
7. A. Kastrati, A. Schoemig, S. Elezi, H. Schuehlen, J. Dirschinger, and M. Hadamaitzky Predictive factors of restenosis after coronary stent placement JACC 30 1997 1428 1436
8. A. Kastrati, A. Schoemig, E. Shpend, H. Schuehlen, M. Wilhelm, and J. Dirschinger Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions Circulation 97 1998 2396 2401
9. P. Wilson Established risk factors and coronary artery disease: the Framingham study Am J Hypertens 7 1994 7 12
10. G.B. Mancini, B. Dahlof, and J. Diez Surrogate markers for cardiovascular disease: structural markers Circulation 109 25 Suppl 1 2004 IV22 IV30
11. J.N. Cohn, A.A. Quyyumi, N.K. Hollenberg, and K.A. Jamerson Surrogate markers for cardiovascular disease: functional markers Circulation 109 25 Suppl 1 2004 IV31 IV46
12. J. Selhub, P.F. Jaques, P.W.F. Wilson, D. Rush, and I.C.H. Rosenberg Vitamin status and intake as primary determinants of homocysteinemia in an elderly population J Am Med Assoc 270 1993 2693 2698
13. N. Weiss, S. Heydrick, Y.Y. Zhang, C. Bierl, A. Cap, and J. Loscalzo Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice Arterioscler Thromb Vasc Biol 22 2002 34 41
14. J.C. Tsai, M.A. Perella, M. Yoshizumi, C.M. Hsieh, E. Haber, and R. Schlegel Promotion of vascular smooth muscle cell growth by homocysteine: a link to artherosclerosis Proc Natl Acad Sci U S A 91 1994 6369 6373
15. D. Jacobsen Homocysteine and vitamins in cardiovascular diseases Clin Chem 44 1998 1833 1843
16. P. Durand, C.S. Lussier, and D. Blache Acute methionine load-induced Hhcy enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats FASEB J 1997 1157 1168
17. J.W. Eikelboom, E. Lonn, J.J. Genest, G. Hankey, and S. Yusuf Homocysteine and cardiovascular disease: a critical review of the epidemiological evidence Ann Intern Med 131 1999 363 375
18. G.N. Welch, and J. Loscalzo Homocysteine and atherothrombosis N Engl J Med 338 1998 1042 1050
19. O. Nygard, J.E. Nordrehaug, H. Refsum, P.M. Ueland, M. Farstad, and S.E. Vollset Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 1997 230 236
20. J. Geisel, B. Hennen, U. Huebner, J.P. Knapp, and W. Herrmann The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease Clin Chem Lab Med 41 2003 1513 1517
21. G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O.M. Hess Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty Eur Heart J 23 2002 726 733
22. G. Schnyder, Y. Flammer, M. Roffi, R. Pin, and O.M. Hess Plasma homocysteine levels and late outcome after coronary angioplasty J Am Coll Cardiol 40 2002 1769 1776
23. S.A. Kojoglanian, M.B. Jorgensen, G. Wolde-Tsadik, R.J. Burchette, and V.J. Aharonian Restenosis in intervented coronaries with hyperhomocysteinemia (RICH) Am Heart J 146 2003 1077 1081
24. P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, M. Aquilina, and L. Corliano Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina Ital Heart J 5 2004 189 196
25. I. Hodish, S. Matetzky, B.A. Sela, V. Guetta, I. Goldenberg, and R. Doolman Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention Cardiology 97 2002 214 217
26. M. Haude, T.F. Konorza, U. Kalnins, A. Erglis, K. Saunamaki, and H.D. Glogar Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients Circulation 107 9 2003 (Mar 11) 1265 1270
27. D.R. Holmes Jr. In-stent restenosis Rev Cardiovasc Med 2 3 2001 115 119
28. A. Kastrati, A. Schoemig, S. Elezi, J. Dirschinger, J. Mehilli, and H. Schuehlen Prognostic value of the modified American College of Cardiology/American Heart Association Stenosis Morphology Classification for long-term angiographic and clinical outcome after coronary stent placement Circulation 100 1999 1285 1290
29. G. Noel, L. Feuvret, J. Bourhis, F. Pousset, A. Gerbaulet, and Y. Popowiski Role of intravascular brachytherapy in the prevention of vascular restenosis after angioplasty Cancer Radiother 2 1998 325-227
30. P. Libby, and S.K. Clinton Cytokines as mediators of vascular pathology Nouv Rev Fr Hematol 34 1992 47 53
31. A. Folsom, J. Nieto, P. McGovern, M. Tsai, R. Malinow, and J. Eckfeldt Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The atherosclerotic risk in communities (ARIC) study Circulation 98 1998 204 210
32. E. Mayer, D. Jacobsen, and K. Robinson Homocysteine and coronary artherosclerosis J Am Coll Cardiol 27 1996 517 527
33. G. Hankey, and J. Eikelboom Homocysteine and vascular disease Lancet 354 1999 407 413
34. A. Bostom, H. Silbershatz, I. Rosenberg, J. Selhub, R. D'Agostino, and P. Wolf Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women Arch Intern Med 159 1999 1077 1080
35. M. Pahor, M. Elam, R. Garrison, S. Kritchevsky, and W. Applegate Emerging noninvasive biochemical measures to predict cardiovascular risk Arch Intern Med 159 1999 237 245
36. T. Kosokabe, K. Okumura, T. Sone, J. Kondo, H. Tsuboi, and H. Mukawa Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting Circulation 103 2001 2048 2054
37. S.D. Kumbasar, I. Dincer, F. Ertas, S. Gulec, C. Erol, and O. Akyurek Hyperhomocysteinemia and restenosis J Cardiovasc Risk 8 2001 9 13
38. W. Koch, G. Ndrepepa, J. Mehilli, S. Braun, M. Burghartz, and H. Lengnick Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries Arterioscler Thromb Vasc Biol 23 2003 2229 2234
39. M.N. Zairis, J.A. Ambrose, S.J. Manousakis, A.S. Stefanidis, O. Papadaki, and H.I. Bilianou The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study J Am Coll Cardiol 40 2002 1375 1382
40. S. Elezi, A. Kastrati, and F.J. Neumann Vessel size and long-term outcome after coronary stent placement Circulation 98 1998 1875 1880
41. T. Akiyama, I. Moussa, and B. Reiners Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels JACC 32 1998 1610 1618